Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid

• Status: Active, not recruiting
• Trial end date: 2021-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the proposed study is to evaluate the effects of administering intravenous tranexamic acid (TXA) to patients undergoing tibial tubercle osteotomy (TTO) to minimize hemarthrosis within the knee joint and post-operative pain.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Patients undergoing TTO

• Age 18-60

• Willing and able to provide consent

Exclusion Criteria:

• Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects, dementia, etc.)

• Younger than 18 years of age

• Older than 60 years of age

• Any patient considered a vulnerable subject

• Have bleeding or clotting disorder

• Preoperative anticoagulation therapy

• Abnormal coagulation profile

• Renal disorder or insufficiency

• Sickle cell disease